on Aspire Biopharma, Inc. (NASDAQ:PWUP)
Aspire Biopharma to Participate in Sidoti Virtual Investor Conference
On May 8, 2025, Aspire Biopharma Holdings, Inc. announced its participation in the Sidoti Virtual Investor Conference scheduled for May 21 at 2:30 PM Eastern. Kraig Higginson, CEO of Aspire, will present the company's advancements and strategy. The presentation is accessible online, offering investors an opportunity to engage directly with the company.
Aspire will also conduct virtual one-on-one meetings with investors on May 21 and 22. These sessions provide a platform for detailed discussions about Aspire's innovative drug delivery technology. Attendees can register via the Sidoti platform or Aspire's website, where a replay of the presentation will also be available.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Aspire Biopharma, Inc. news